Biotech startups in Oxford, United Kingdom
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Brainomix | Oxford | Series C | $6.5M | 2026-02-24 |
| Infinitopes | Oxford | Seed | $15.4M | 2026-01-21 |
| Genomics | Oxford | Series C | $44.6M | 2024-01-08 |
| OXCCU | Oxford | Series B | $27.9M | 2025-09-29 |
| Sitryx Therapeutics | Oxford | Series A | $39.0M | 2023-09-27 |
| Fermtech | Oxford | Seed | $3.3M | 2026-04-07 |
| OxCan | Oxford | Series A | $11.0M | 2025-01-09 |
| ONI | Oxford | Series B | $75.0M | 2021-12-24 |
8 rows of the CSV in 5 of its 18 columns.
- The 47 biotech startups in Oxford, United Kingdom have raised $1.5B in total.
- 8 of them closed their most recent round in the last 12 months, $389.2M combined.
- The largest of those rounds is OMass Therapeutics' $310.0M Series C, dated October 2026.
- Oxford Science Enterprises is an investor in 7 of them, more than any other fund.
- Health care is the most common other sector, with 31 companies (66%).
- 36% were founded in 2020 or later; the median founding year is 2018.
- The most common team size is 11 to 50 employees (49% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
12 of 47| Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|
| Fermtech | Fermtech provides equipment that helps precision fermentation companies scale production processes. | Biotech | Seed | $3.3M | 2026-04-07 | $3.9M | Carbon13 | 1 to 10 | 2022 |
| Brainomix | Brainomix creates AI-powered imaging biomarkers that support precision medicine treatment decisions. | Artificial intelligence | Series C | $6.5M | 2026-02-24 | $60.2M | Innovate UK, Parkwalk Advisors, Boehringer Ingelheim Venture Fund +1 | 51 to 100 | 2010 |
| Infinitopes | Infinitopes develops vaccines for the treatment of cancer. | Biotech | Seed | $15.4M | 2026-01-21 | $31.4M | Octopus Ventures, Kindred Capital, Martlet Capital +1 | 11 to 50 | 2021 |
| OXCCU | OXCCU converts carbon dioxide and hydrogen into synthetic fuels, chemicals, and biodegradable plastics. | Biotech | Series B | $27.9M | 2025-09-29 | $54.1M | IP Group, Aramco Ventures, Clean Energy Ventures +1 | 1 to 10 | 2021 |
| OxCan | OxCan develops machine learning and liquid biopsy tools for early lung cancer detection. | Biotech | Series A | $11.0M | 2025-01-09 | $16.4M | Civilization Ventures, Eka Ventures, Oxford Technology Management +1 | 11 to 50 | 2020 |
| Oxford Endovascular | Oxford Endovascular develops a novel treatment for brain aneurysms. | Biotech | Series A | $10.2M | 2024-05-20 | $28.4M | Innovate UK, MedTech Innovator, Parkwalk Advisors +1 | 1 to 10 | 2015 |
| Pathios Therapeutics | Pathios Therapeutics develops therapies for autoimmune diseases and cancer. | Biotech | Series B | $25.0M | 2024-04-18 | Innovate UK, Canaan Partners, Bristol-Myers Squibb +2 | 1 to 10 | 2017 | |
| Genomics | Genomics plc works to bring genomic medicine into healthcare. | Biotech | Series C | $44.6M | 2024-01-08 | $135.4M | Innovate UK, IP Group, Oxford Science Enterprises +1 | 101 to 250 | 2014 |
| Sitryx Therapeutics | Sitryx Therapeutics develops disease-modifying therapeutics in immuno-oncology and immuno-inflammation. | Biotech | Series A | $39.0M | 2023-09-27 | Sofinnova Partners, Oxford Science Enterprises, SV Health Investors +1 | 11 to 50 | 2018 | |
| ONI | ONI makes super-resolution microscopy accessible to new generations of researchers. | Biotech | Series B | $75.0M | 2021-12-24 | $109.4M | Puhua Capital, Future Planet Capital, Oxford Science Enterprises +2 | 101 to 250 | 2016 |
| Arctoris | Arctoris combines robotics and data science to accelerate biotechnology drug discovery. | Artificial intelligence | Seed | $8.0M | 2019-07-01 | Future Planet Capital, Eurostars, Tanarra Capital +1 | 11 to 50 | 2016 | |
| EnzBond | EnzBond develops enzymes for pharmaceutical use through in-silico methods. | Biotech | Seed | $445K | 2016-12-05 | Oxford Science Enterprises | 1 to 10 | 2016 |
Table 1. Biotech startups in Oxford, United Kingdom: the 12 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 47.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Infinitopes | Infinitopes develops vaccines for the treatment of cancer. | Biotech | Seed | $15.4M | 2026-01-21 | $31.4M | Octopus Ventures, Kindred Capital, Martlet Capital +1 | 11 to 50 | 2021 |
| 2 | Brainomix | Brainomix creates AI-powered imaging biomarkers that support precision medicine treatment decisions. | Artificial intelligence | Series C | $6.5M | 2026-02-24 | $60.2M | Innovate UK, Parkwalk Advisors, Boehringer Ingelheim Venture Fund +1 | 51 to 100 | 2010 |
| 3 | Fermtech | Fermtech provides equipment that helps precision fermentation companies scale production processes. | Biotech | Seed | $3.3M | 2026-04-07 | $3.9M | Carbon13 | 1 to 10 | 2022 |
Table 2. Biotech startups in Oxford, United Kingdom: the 3 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Oxford Science Enterprises | Venture capital firm | Oxford, United Kingdom | 7 | 15% | ||
| 2 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 4 | 9% | 1 | Brainomix |
| 3 | Parkwalk Advisors | Venture capital firm | London, United Kingdom | 2 | 4% | 1 | Brainomix |
| 4 | IP Group | Venture capital firm | London, United Kingdom | 2 | 4% | ||
| 5 | Future Planet Capital | Venture capital firm | London, United Kingdom | 2 | 4% | ||
| 6 | Oxford University Innovation | University program | Oxford, United Kingdom | 1 | 2% | 1 | Brainomix |
| 7 | Boehringer Ingelheim Venture Fund | Corporate venture arm | Ingelheim Am Rhein, Germany | 1 | 2% | 1 | Brainomix |
| 8 | Manta Ray Ventures | Venture capital firm | London, United Kingdom | 1 | 2% | 1 | Infinitopes |
| 9 | Kindred Capital | Venture capital firm | London, United Kingdom | 1 | 2% | 1 | Infinitopes |
| 10 | Octopus Ventures | Venture capital firm | London, United Kingdom | 1 | 2% | 1 | Infinitopes |
| 11 | Martlet Capital | Venture capital firm | Cambridge, United Kingdom | 1 | 2% | 1 | Infinitopes |
| 12 | Invesco | Hedge fund | Atlanta, United States | 1 | 2% | ||
| 13 | TechEnergy Ventures | Corporate venture arm | Buenos Aires, Argentina | 1 | 2% | ||
| 14 | Aramco Ventures | Corporate venture arm | Dhahran, Saudi Arabia | 1 | 2% | ||
| 15 | Clean Energy Ventures | Venture capital firm | Boston, United States | 1 | 2% |
Table 3. Biotech startups in Oxford, United Kingdom: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 31 | 66% | $1.3B |
| Software | 11 | 23% | $255.9M |
| Artificial intelligence | 6 | 13% | $131.1M |
| Energy | 2 | 4% | $54.1M |
| Hardware | 1 | 2% | |
| Education | 1 | 2% |
Table 4. Biotech startups in Oxford, United Kingdom by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Pre-seed | 2 | 4% | $500K |
| Seed | 20 | 43% | $4.6M |
| Series A | 11 | 23% | $27.0M |
| Series B | 9 | 19% | $27.9M |
| Series C | 5 | 11% | $85.0M |
Table 5. Biotech startups in Oxford, United Kingdom by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 3 | 38% | $345.0M |
| July 2026 | 1 | 12% | $15.0M |
| April 2026 | 2 | 25% | $7.3M |
| February 2026 | 1 | 12% | $6.5M |
| January 2026 | 1 | 12% | $15.4M |
Table 6. Biotech startups in Oxford, United Kingdom: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 8 | 17% | $389.2M |
| 2025 | 3 | 6% | $99.4M |
| 2024 | 4 | 9% | $80.3M |
| 2023 | 5 | 11% | $43.6M |
| 2022 | 5 | 11% | $257.3M |
| 2021 | 7 | 15% | $185.2M |
Table 7. Biotech startups in Oxford, United Kingdom by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 1 | 2% |
| 2020 to 2022 | 16 | 34% |
| 2015 to 2019 | 22 | 47% |
| 2010 to 2014 | 7 | 15% |
| Before 2010 | 1 | 2% |
Table 8. Biotech startups in Oxford, United Kingdom by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 17 | 36% |
| 11 to 50 | 23 | 49% |
| 51 to 100 | 1 | 2% |
| 101 to 250 | 6 | 13% |
Table 9. Biotech startups in Oxford, United Kingdom by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its headquarters is in Oxford, United Kingdom. On 16 November 2026 that is 47 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 12 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 47 rows: 10 have no round amount, 0 no city and 16 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Oxford, United Kingdom are on the list?
- 47, in the file dated 16 November 2026. 8 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 47 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.